Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
CLEAR III期研究在晚期肾细胞癌患者中的应用:乐伐替尼联合帕博利珠单抗组和舒尼替尼组的亚组疗效
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1223282
Grünwald, Viktor; Powles, Thomas; Eto, Masatoshi; Kopyltsov, Evgeny; Rha, Sun Young; Porta, Camillo; Motzer, Robert; Hutson, Thomas E; Méndez-Vidal, María José; Hong, Sung-Hoo; Winquist, Eric; Goh, Jeffrey C; Maroto, Pablo; Buchler, Tomas; Takagi, Toshio; Burgents, Joseph E; Perini, Rodolfo; He, Cixin; Okpara, Chinyere E; McKenzie, Jodi; Choueiri, Toni K